In 2020, the IFF initiated a total 34 doping controls, which is less than during previous years as the Covid-19 effected the planned activities. There were no anti-doping rule violations in the IFF initiated tests.

– The amount of doping controls was significantly lower than originally planned due to the  Covid-19 pandemic that effected many of the planned events both on the national and international level. There were still some tests conducted during the year, and the Anti-Doping Organisations are following the Covid-19 testing guidelines published by the World Anti-Doping Agency (WADA), IFF Communications and Anti-Doping Manager Merita Bruun informs.

WADA Covid-19 updates including testing guidelines and Q & A documents for athletes are available here!

Out of these 34 IFF tests, 16 tests were conducted in the IFF Events (in-competition tests) and 18 were IFF out-of-competition tests including three samples analysed for ESAs (urine) and three samples analysed for GHRFs (urine).

Samples analysed for Erythropoiesis Stimulating Agents (ESAs, e.g. EPO) and Growth Hormone (GH)/Growth Hormone Releasing Factors (GHRFs) are on a 5 % level in floorball. This meets the requirements of the WADA Technical Document for Sport Specific Analysis (TDSSA). The objective of the TDSSA is to protect clean athletes by establishing Minimum Level Analysis for those prohibited substances that are at risk of abuse in particular sports. The 2021 WADA TDSSA is found here.

The IFF doping control statistics are found here.